Choriogonadotropin, also known as human chorionic gonadotropin (hCG), is a hormone that plays a crucial role in human reproduction. It is produced by the syncytiotrophoblast, a component of the fertilized egg and subsequent placenta. This glycoprotein hormone is composed of two subunits, alpha and beta, where the alpha subunit is essentially identical to that of other hormones like LH, FSH, and TSH. The beta subunit provides its unique chemical identity. The primary function of hCG is to maintain the corpus luteum during the beginning of pregnancy, which in turn continues to secrete progesterone to sustain the uterine lining. The hormone's presence is also the biochemical marker for pregnancy tests, as its levels rise rapidly following implantation. In addition to its critical role in gestation, hCG also influences the maternal immune system to protect the fetus during the early stages of pregnancy.
There are a variety of chemical compounds that could potentially upregulate the expression of choriogonadotropin. These activators are diverse in nature and exert their effects on different points of the biochemical pathways that govern hormone balance and expression. For instance, compounds such as selective estrogen receptor modulators can prompt the hypothalamus to release more gonadotropin-releasing hormone (GnRH), which in turn stimulates the pituitary gland to secrete hormones like LH. Such stimulation could lead to an indirect upsurge in hCG levels. Similarly, substances that suppress estrogen production may cause a feedback loop response that triggers the pituitary to produce more gonadotropins, potentially elevating hCG expression. Additionally, chemicals that interfere with the endocrine function or disrupt hormonal homeostasis, even those not directly related to the reproductive system, may incite a compensatory response that includes an increase in hCG levels. It's important to recognize that while these compounds can influence the expression of choriogonadotropin, they operate within a complex and tightly regulated system, which is subject to a multitude of checks and balances within the body's hormonal milieu.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Clomiphene Citrate | 50-41-9 | sc-205636 sc-205636A | 1 g 5 g | $84.00 $176.00 | 1 | |
Clomiphene citrate, as a selective estrogen receptor modulator, can lead to an increase in gonadotropin-releasing hormone, potentially stimulating the expression of choriogonadotropin. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Tamoxifen, by exerting partial estrogen agonist effects, may prompt the pituitary gland to secrete luteinizing hormone, which can lead to the upregulation of choriogonadotropin secretion. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Ketoconazole can lead to a reduction in androgen synthesis, which might trigger a compensatory upregulation of gonadotropins, potentially including choriogonadotropin, as a secondary effect. | ||||||
Mifepristone | 84371-65-3 | sc-203134 | 100 mg | $61.00 | 17 | |
Mifepristone has the potential to elevate gonadotropin levels by antagonizing glucocorticoid receptors, which may indirectly induce the upregulation of choriogonadotropin. | ||||||
Buserelin | 57982-77-1 | sc-353114 sc-353114A | 1 mg 5 mg | $190.00 $746.00 | ||
Buserelin, as a gonadotropin-releasing hormone agonist, could cause an increase in luteinizing hormone, leading to a secondary rise in choriogonadotropin levels. | ||||||
Letrozole | 112809-51-5 | sc-204791 sc-204791A | 25 mg 50 mg | $87.00 $147.00 | 5 | |
Letrozole, by decreasing estrogen synthesis, can cause a compensatory increase in gonadotropin levels, which may include the upregulation of choriogonadotropin secretion. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate, by interfering with folate metabolism, could disrupt normal cell replication processes, potentially triggering an increase in compensatory hormonal responses including choriogonadotropin. | ||||||
Danazol | 17230-88-5 | sc-203021 sc-203021A | 100 mg 250 mg | $92.00 $238.00 | 3 | |
Danazol, through its androgenic activity, may lead to a reduction in sex hormone-binding globulin levels, which could result in a surge of free gonadotropins, potentially stimulating choriogonadotropin secretion. | ||||||
Diethylstilbestrol | 56-53-1 | sc-204720 sc-204720A sc-204720B sc-204720C sc-204720D | 1 g 5 g 25 g 50 g 100 g | $71.00 $287.00 $547.00 $1098.00 $2185.00 | 3 | |
Diethylstilbestrol, as a synthetic nonsteroidal estrogen, could induce hypersecretion of gonadotropins from the pituitary gland, potentially leading to increased choriogonadotropin levels. | ||||||